The CAS (Chinese Academy of Science) had arranged a series of lectures and discussions at its relevant specialised research institutes for microbiology and immunology, genome research, pharmacology, natural sciences, biochemistry and bio-informatics technology for Professor Dr. Wittig, chairman of the executive board of MOLOGEN AG. Professor Wittig said, “Directors of the internationally outstanding scientific institutes and heads of research teams wanted to learn about the MOLOGEN’s dSLIM technology, which we call DNABarrier, for defence against infections. Chinese research colleagues gave their opinions on DNABarrier and both sides were delighted by the quality, intensity and breadth of the ensuing discussions”.
